1. Home
  2. MGRX vs LGVN Comparison

MGRX vs LGVN Comparison

Compare MGRX & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mangoceuticals Inc.

MGRX

Mangoceuticals Inc.

BUY

Current Price

$0.26

Market Cap

7.1M

Sector

Technology

ML Signal

BUY

Logo Longeveron Inc.

LGVN

Longeveron Inc.

BUY

Current Price

$1.59

Market Cap

7.8M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
MGRX
LGVN
Founded
2021
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
7.8M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
MGRX
LGVN
Price
$0.26
$1.59
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $61.25
AVG Volume (30 Days)
★ 522.9K
69.7K
Earning Date
11-13-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 55.17
50.76
EPS
★ N/A
N/A
Revenue
$456,021.00
★ $709,000.00
Revenue This Year
N/A
$46.15
Revenue Next Year
N/A
$396.46
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.26
$0.48
52 Week High
$2.50
$7.60

Technical Indicators

Market Signals
Indicator
MGRX
LGVN
Relative Strength Index (RSI) 30.21 33.00
Support Level N/A $0.61
Resistance Level $0.49 $7.30
Average True Range (ATR) 0.04 0.22
MACD -0.02 -0.05
Stochastic Oscillator 2.60 16.28

Price Performance

Historical Comparison
MGRX
LGVN

About MGRX Mangoceuticals Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: